Tablet-Based Assessment of Picture Naming in Prodromal Alzheimer's Disease: An Accessible and Effective Tool for Distinguishing Mild Cognitive Impairment from Normal Aging
- PMID: 40499520
- PMCID: PMC12240569
- DOI: 10.1159/000546451
Tablet-Based Assessment of Picture Naming in Prodromal Alzheimer's Disease: An Accessible and Effective Tool for Distinguishing Mild Cognitive Impairment from Normal Aging
Abstract
Introduction: Effective mild cognitive impairment (MCI) screening requires accessible testing. This study compared two tests for distinguishing MCI patients from controls: rapid automatized naming (RAN) for naming speed and low-contrast letter acuity (LCLA) for sensitivity to low-contrast letters.
Methods: Two RAN tasks were used: the Mobile Universal Lexicon Evaluation System (MULES, picture naming) and the Staggered Uneven Number test (SUN, number naming). Both RAN tasks were administered on a tablet and in a paper/pencil format. The tablet format was administered using the Mobile Integrated Cognitive Kit application. LCLA was tested at 2.5% and 1.25% contrast.
Results: Sixty-four participants (31 MCI, 34 controls; mean age 73.2 ± 6.8 years) were included. MCI patients were slower than controls for paper/pencil (75.0 vs. 53.6 s, p < 0.001), and tablet MULES (69.0 s vs. 50.2 s, p = 0.01). The paper/pencil SUN showed no significant difference (MCI: 59.5 s vs. controls: 59.9 s, p = 0.07) nor did the tablet SUN (MCI: 59.3 s vs. controls: 55.7 s, p = 0.36). MCI patients had worse performance on LCLA testing at 2.5% contrast (33 letters vs. 36, p = 0.04*) and 1.25% (0 letters vs. 14 letters, p < 0.001). Receiver operating characteristic (ROC) analysis showed similar performance of paper/pencil and tablet MULES in distinguishing MCI from controls (area under the ROC curve [AUC] = 0.77), outperforming both SUN (AUC = 0.63 paper, 0.59 tablet) and LCLA (2.5% contrast: AUC = 0.65, 1.25% contrast: AUC = 0.72).
Conclusion: The MULES, in both formats, may be a valuable screening tool for MCI.
Keywords: Aging and cognition; Alzheimer’s dementia; Assessment measures; Cognitive aging; Cognitive impairment; Cognitive screening test; Contrast sensitivity; Digital assessment; Mild cognitive impairment; Rapid automatized naming task; Visual acuity.
© 2025 The Author(s). Published by S. Karger AG, Basel.
Conflict of interest statement
Dr. Arjun V. Masurkar is a council member of the Alzheimer’s Association International Research Grant Program and a steering committee member of the Alzheimer’s Disease Cooperative Study and serves on the Editorial Board of Alzheimer’s and Dementia: Translational Research and Clinical Interventions. The authors declare no conflicts of interest. The authors affirmed that these affiliations did not influence the content or integrity of this manuscript.
Figures





Similar articles
-
Mini-Mental State Examination (MMSE) for the detection of Alzheimer's disease and other dementias in people with mild cognitive impairment (MCI).Cochrane Database Syst Rev. 2015 Mar 5;2015(3):CD010783. doi: 10.1002/14651858.CD010783.pub2. Cochrane Database Syst Rev. 2015. Update in: Cochrane Database Syst Rev. 2021 Jul 27;7:CD010783. doi: 10.1002/14651858.CD010783.pub3. PMID: 25740785 Free PMC article. Updated.
-
Exploration of Rapid Automatized Naming and Standard Visual Tests in Prodromal Alzheimer Disease Detection.J Neuroophthalmol. 2022 Mar 1;42(1):79-87. doi: 10.1097/WNO.0000000000001228. Epub 2021 May 17. J Neuroophthalmol. 2022. PMID: 34029274 Free PMC article.
-
CSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).Cochrane Database Syst Rev. 2017 Mar 22;3(3):CD010803. doi: 10.1002/14651858.CD010803.pub2. Cochrane Database Syst Rev. 2017. PMID: 28328043 Free PMC article.
-
18F PET with florbetapir for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).Cochrane Database Syst Rev. 2017 Nov 22;11(11):CD012216. doi: 10.1002/14651858.CD012216.pub2. Cochrane Database Syst Rev. 2017. PMID: 29164603 Free PMC article.
-
18F PET with flutemetamol for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).Cochrane Database Syst Rev. 2017 Nov 22;11(11):CD012884. doi: 10.1002/14651858.CD012884. Cochrane Database Syst Rev. 2017. PMID: 29164602 Free PMC article.
References
-
- Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, et al. The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011;7(3):270–9. - PMC - PubMed
-
- Petersen RC. Mild cognitive impairment: transition from aging to Alzheimer’s disease. Alzheimer’s Dis. 2001:141–51. - PubMed
-
- Jones A, Ali MU, Mayhew A, Aryal K, Correia RH, Dash D, et al. Environmental risk factors for all-cause dementia, Alzheimer’s disease dementia, vascular dementia, and mild cognitive impairment: an umbrella review and meta-analysis. Environ Res. 2025;270:121007. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous